Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY real-world study of adalimumab for moderate to severe hidradenitis suppurativa
MOH_2017-02-06_000094Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in hidradenitis suppurativa (HS), sponsored by AbbVie Inc. Primary endpoint: Effectiveness of adalimumab by disease severity. Started Mar 2016; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on MOH_2017-02-06_000094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-02-06_000094.